Acme Universal Safezone 9 IPO
Upcoming28–30 Sep 2026
What stands out in the offer document
The five questions
-
1How it makes money₹92 of every ₹100 of sales comes from its "Domestic Sales" segment. ₹95 of every ₹100 comes from India and United Arab Emirates (UAE).
-
2Is it growing, and is profit turning into cash?Sales rose 15% from 2024 to 2026 (₹179 cr → ₹206 cr). Over 3 years it made ₹14.2 cr of profit and brought in ₹30.9 cr of cash from operations.
-
3How much cushion does it have?It owes ₹1.10 for every ₹1 of its own money. The line for manufacturing is ₹2.
-
4What you pay, and who gets the moneyAll the money raised goes to the company. At ₹71 you pay about ₹17 for every ₹1 of last year's profit.
-
5Who controls it, and what is on record?Promoters own 95% before the IPO. The document discloses 1 legal matter.
Latest update:
Price band ₹65–₹71 · Closes 30 Sep 2026 · Allotment 1 Oct 2026 (Confirmed) · Lists 6 Oct 2026 (Expected)
What Acme Universal Safezone 9 does
Acme Universal Safezone 9 Limited is engaged in the manufacturing and supply of industrial safety footwear under the brand name 'ACME'. The company serves diverse sectors including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry, and power generation through 15 product lines.
Acme Universal Safezone 9 financials
Rs crore · AnnualLatest year highlighted in green. Sparklines show the trend.
| 2024 | 2025 | 2026 | ||
|---|---|---|---|---|
| Sales | 179 | 187 | 206 | |
| Operating Profit | 15 | 10 | 15 | |
| OPM % | 8.1% | 5.3% | 7.4% | |
| Net Profit | 8 | 1 | 6 | |
| Total Debt | 45 | 50 | 58 |
Acme Universal Safezone 9 IPO offer structure
Fresh issue: ₹36 cr
The offer-for-sale component is not stated in what we extracted from the offer document, so the full issue size and the split between the two are unknown. This figure is the fresh issue alone, not the total raise. Fresh issue proceeds go to the company; OFS proceeds go to selling shareholders.
Issue size and split come from a public aggregator rather than the exchange, cross-checked against a second one. The offer document states the offer-for-sale as a share count against a blank amount, so it cannot be read from the document itself.
Use of proceeds- Funding capital expenditure requirements for the installation of solar power plant: ₹4 cr
- Funding capital expenditure requirements towards installation of additional machinery: ₹9 cr
- Funding incremental working capital requirements of our Company: ₹8 cr
- Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
Acme Universal Safezone 9 promoters and holding
- Nitin Tiwari: Managing Director
- Ruchi Tiwari: Executive Director
Acme Universal Safezone 9 strengths and risks
Company-stated strengths and disclosed risk factors from the offer document.
- Manufacturing Scale and Location with four co-located facilities. (p.143)
- Automation and Technology including Desma PU direct injection machines and Orisol automated stitching. (p.143)
- Product Range and Standards Compliance with 15 product lines complying with IS 15298, EN ISO 20345, and ASTM F2413. (p.143)
- In-house dedicated R&D unit and product testing laboratory. (p.143)
- Export Presence and International Standards Compliance serving UAE, Bahrain, Saudi Arabia, Nigeria, and others. (p.143)
- Our Offices and Plants are located on leased premises and any disruption in these lease arrangements could adversely affect our business. (p.27)
- Significant portion of our revenue has been generated from some states of India, any loss of business from these states may adversely affect our revenues. (p.27)
- Our revenue is highly concentrated among a small number of customers, with the top 10 customers accounting for 47.71% for the Financial Year ended March 31, 2026. (p.28)
- Our failure to perform in accordance with the standards prescribed in work order of our client could result in loss of business. (p.28)
- Our Company has consolidated its manufacturing operations by shifting production from its Dada Nagar units to its Banthar facility. (p.29)
Acme Universal Safezone 9 peer comparison: DRHP median P/E 40.8x
DRHP data only| Company | CMP | P/E | OPM% | ROE% | Source |
|---|---|---|---|---|---|
| Liberty Shoes Limited | — | 40.8x | — | — | DRHP |
| Superhouse Limited | — | 54.7x | — | — | DRHP |
| Mallcom (India) Limited | — | 20.8x | — | — | DRHP |
P/E from offer document where live data unavailable. Not a fair-value judgement.
Acme Universal Safezone 9 market and competition
As per World Trade Data for CY 2024, India ranks as the 4th largest exporter of safety footwear globally. At the forefront of the organized segment are leading domestic players such as Bata Industrials, Liberty Warrior, Hillson, Acme, Karam Industries, and Safari Pro.
Acme Universal Safezone 9 outlook, as the document states it
The Company focuses on expanding its production capacity and strengthening its market presence to capitalize on growing demand in the safety footwear industry. Key strategies include process automation, technology upgradation, product development, and geographic expansion in the Middle East, United States, and Europe.
Never miss an IPO like this
Every upcoming IPO analysed: subscription, GMP and a DRHP breakdown, in your inbox, free. One email when each one opens.
Acme Universal Safezone 9 IPO: common questions
When does the Acme Universal Safezone 9 IPO open and close?
The Acme Universal Safezone 9 IPO is open from 28 Sep 2026 to 30 Sep 2026.
What is the Acme Universal Safezone 9 IPO price band?
The price band is ₹65–₹71 per share.
What is the lot size and minimum investment for the Acme Universal Safezone 9 IPO?
One lot is 1600 shares, and a retail application must be at least one lot. That is about ₹2,27,200 at the upper end of the band. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category.
When are the Acme Universal Safezone 9 IPO allotment and listing dates?
Not published yet. Derived from the close date on the usual timetable: allotment around 1 Oct 2026, refund/unblock around 2 Oct 2026 and listing around 6 Oct 2026. Treat these as estimates until the exchange confirms them.
How do I apply for the Acme Universal Safezone 9 IPO?
Through any broker app or your bank's net banking, using a demat account and a PAN. You bid in lots at a price inside the band, or at cut-off. The money is blocked in your account, not debited, until allotment. One application per PAN. Bidding opens 28 Sep 2026. We do not recommend brokers and carry no broker links. How to apply, start to finish →
Sources & method
Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.
Grey-market premium (GMP) is unregulated.
Every GMP figure is a self-reported grey-market estimate. No exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer → Has GMP actually been right? →
How often do these actually open above the issue price?
Of the 712 SME IPOs that have listed on the NSE since 2016, 564 (79%) opened above their issue price, at a median of +11%. That is the segment's own record, not a forecast for this issue.